Direct-Acting Oral Anticoagulants and Potential Inconsistencies with FDA-Approved Dosing for Non-Valvular Atrial Fibrillation: A Retrospective Real-World Analysis Across Nine US Healthcare Systems.
DeLor B, Glover JJ, Hartman TJ, Manzey LL, Ateya M, Kelsh S, Taylor K, Zemrak WR, Gowen JR, Parks A, Gust C, Medico C, Akpoji UC, Naylor S, Chou CW, Fakelmann G, Hart S, Wiethorn EE, Trinh T, Wilson WW, Bowen R, Stanton J, Duvall L, Davis LT; D-DARE Consortium.
DeLor B, et al. Among authors: parks a.
J Gen Intern Med. 2024 Oct 18. doi: 10.1007/s11606-024-09106-w. Online ahead of print.
J Gen Intern Med. 2024.
PMID: 39424771